Atopic Dermatitis and Food Triggers
Atopic dermatitis (AD) can cause red, itchy skin flares linked to food allergies, but only 30% of people with AD have food triggers. It's important to see a doctor before…
Study Suggests Mind-Body Benefits of GLP-1s
An analysis of health records found that people using GLP-1 medications for weight loss or diabetes were less likely to develop new diagnoses of depression or anxiety. This correlation was…
Best Eye Drops For 2024: Revitalize Your Vision
The article explains that dry eyes can cause discomfort and blurred vision, and provides tips for selecting the best eye drops for dry eyes. It also lists the best eye…
CDSCO Panel Tells Boehringer Ingelheim
The Central Drugs Standard Control Organization (CDSCO) panel has requested further study on the safety and effectiveness of using tenecteplase at a dosage of 0.25 mg/kg for treating acute ischemic…
Limiting Cyberattack Blast Radius for Healthcare SaaS
Attorneys filed suit against Johns Hopkins University and its health system, alleging that they failed to secure IT systems, resulting in a theft of sensitive patient data. The lawsuit mentions…
Campaign highlights stories of people living with rare diseases
A new campaign called ‘I am Number 17’ has been launched in Ireland to raise awareness about rare diseases. The campaign features 17 people sharing their stories to promote understanding…
Adding Fruquintinib to Paclitaxel Improves PFS in Gastric, GEJ Cancer
Fruquintinib plus paclitaxel has shown promising results as a second-line treatment option for patients with advanced gastric or gastroesophageal junction (GEJ) cancer. The combination improved responses and progression-free survival (PFS)…
Mental health platform Headlight launches with $18M and more digital health funding
The tech-enabled mental health platform Headlight has launched with $18 million in funding and offers in-network access to treatment for a variety of mental health conditions. The company aims to…
FDA’s Plan to Ban Hair Relaxer Chemical Called Too Little, Too Late
The Food and Drug Administration is planning to propose a ban on formaldehyde in hair-straightening products, which are popular among Black women. The proposal comes after mounting evidence of health…
What we’ve learned from the Aduhelm mess
STAT publishes selected Letters to the Editor in response to First Opinion essays for robust, good-faith discussion. Jason Karlawish's article on Aduhelm's approval process raises concerns about the roles and…